REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Nzoz Danmed Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Ambulatory Health Care Services | Offices of All Other Miscellaneous Health Practitioners | All Other Miscellaneous Ambulatory Health Care Services
Full name: Nzoz Danmed Sp. z o.o. Profile Updated: April 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Nzoz Danmed Sp. z o.o. is based in Poland, with the head office in Dankowice. The company operates in the General Medical and Surgical Hospitals industry. It was first established on August 13, 2020. The company’s latest financial report indicates a net sales revenue increase of 39.29% in 2023. Its’ total assets recorded a growth of 62.18%. The enterprise’s net profit margin increased by 6.9% in 2023.

Headquarters
Ul. Sw. Wojciecha 23
Dankowice; Slaskie; Postal Code: 43-331

Contact Details: Purchase the Nzoz Danmed Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Nzoz Danmed Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Nzoz Danmed Sp. z o.o. report to view the information.
Incorporation Date:
August 13, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Nzoz Danmed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
39.29%▲
Total operating revenue
39.02%▲
Operating profit (EBIT)
759%▲
EBITDA
342.63%▲
Net Profit (Loss) for the Period
769.99%▲
Total assets
62.18%▲
Total equity
68.8%▲
Operating Profit Margin (ROS)
7.65%▲
Net Profit Margin
6.9%▲
Return on Equity (ROE)
36.02%▲
Quick Ratio
0.48%▲
Cash Ratio
0.43%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo